Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Bever

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Experimental and Molecular Pathology|January 23, 2017
SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosisDaniel Hewes, Alexandru Tatomir, Adam M Kruszewski, et al.
Scientific Reports|September 17, 2021
7,8-Dihydroxyflavone improves neuropathological changes in the brain of Tg26 mice, a model for HIV-associated neurocognitive disorderJoseph Bryant, Sanketh Andhavarapu, Christopher Bever, et al.
Scientific Reports|October 7, 2021
Author Correction: 7,8-Dihydroxyflavone improves neuropathological changes in the brain of Tg26 mice, a model for HIV-associated neurocognitive disorderJoseph Bryant, Sanketh Andhavarapu, Christopher Bever, et al.
Neurology|December 31, 2013
Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of NeurologySarah L Minden, Anthony Feinstein, Rosalind C Kalb, et al.
Experimental and Molecular Pathology|September 25, 2012
Dual role of Response gene to complement-32 in multiple sclerosisCosmin A Tegla, Cornelia D Cudrici, Philippe Azimzadeh, et al.
Experimental and Molecular Pathology|January 9, 2014
SIRT1 is decreased during relapses in patients with multiple sclerosisCosmin A Tegla, Philippe Azimzadeh, Maria Andrian-Albescu, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Experimental and Molecular Pathology|January 23, 2017
SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosisDaniel Hewes, Alexandru Tatomir, Adam M Kruszewski, et al.
Scientific Reports|September 17, 2021
7,8-Dihydroxyflavone improves neuropathological changes in the brain of Tg26 mice, a model for HIV-associated neurocognitive disorderJoseph Bryant, Sanketh Andhavarapu, Christopher Bever, et al.
Scientific Reports|October 7, 2021
Author Correction: 7,8-Dihydroxyflavone improves neuropathological changes in the brain of Tg26 mice, a model for HIV-associated neurocognitive disorderJoseph Bryant, Sanketh Andhavarapu, Christopher Bever, et al.
Neurology|December 31, 2013
Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of NeurologySarah L Minden, Anthony Feinstein, Rosalind C Kalb, et al.
Experimental and Molecular Pathology|September 25, 2012
Dual role of Response gene to complement-32 in multiple sclerosisCosmin A Tegla, Cornelia D Cudrici, Philippe Azimzadeh, et al.
Experimental and Molecular Pathology|January 9, 2014
SIRT1 is decreased during relapses in patients with multiple sclerosisCosmin A Tegla, Philippe Azimzadeh, Maria Andrian-Albescu, et al.
Pageof 2